Recommended Topic Related To:

Lymphazurin

"The U.S. Food and Drug Administration today approved Vimizim (elosulfase alfa), the first FDA-approved treatment for Mucopolysaccharidosis Type IVA (Morquio A syndrome). Morquio A syndrome is a rare, autosomal recessive lysosomal storage disease "...

Lymphazurin

LYMPHAZURIN™
1% (Isosulfan Blue) AQUEOUS SOULTION

DRUG DESCRIPTION

The chemical name of Lymphazurin 1% (isosulfan blue) is N-[4- [[4-(diethylamino)phenyl] (2,5-disulfophenyl) methylene]-2,5- cyclohexadien-1-ylidene]-N-ethylethanaminium hydroxide, inner salt, sodium salt. Its structural formula is:

Lymphazurin (isosulfan blue) structural formula illustration

Lymphazurin (isosulfan blue) 1% is a sterile aqueous solution for subcutaneous administration. Phosphate buffer in sterile, pyrogen free water is added in sufficient quantity to yield a final pH of 6.8-7.4. Each ml of solution contains 10 mg Isosulfan blue, 6.6 mg sodium monohydrogen phosphate and 2.7 mg potassium dihydrogen phosphate. The solution contains no preservative. Lymphazurin (isosulfan blue) 1% is a contrast agent for the delineation of lymphatic vessels.

Last reviewed on RxList: 2/13/2008
This monograph has been modified to include the generic and brand name in many instances.

A A A

Report Problems to the Food and Drug Administration

 

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


Women's Health

Find out what women really need.


NIH talks about Ebola on WebMD